RTP801 is a novel retinoic acid-responsive gene associated with myeloid differentiation

Experimental Hematology

Volumn 35, Issue 4, 2007, Pages 572-578

  Gery, Sigal ^a   Park, Dorothy J ^a   Vuong, Peter T ^a   Virk, Renu K ^a   Muller, Claudia I ^a   Hofmann, Wolf K ^b   Koeffler, H Phillip ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; PROTEIN; PROTEIN RTP801; RETINOIC ACID; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR C EBP EPSILON; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL MATURATION; CELL STRAIN U937; CONTROLLED STUDY; DOWN REGULATION; GENE IDENTIFICATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

ACUTE DISEASE; APOPTOSIS; CELL DIFFERENTIATION; CELL DIVISION; GRANULOCYTES; HUMANS; LEUKEMIA, MYELOID; PHOSPHORYLATION; PROTEIN KINASES; RNA, MESSENGER; TRANSCRIPTION FACTORS; U937 CELLS;

EID: 33947228487     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2007.01.049     Document Type: Article

References (29)

1. Freemantle S.J., Spinella M.J., and Dmitrovsky E. Retinoids in cancer therapy and chemoprevention: promise meets resistance. Oncogene 22 (2003) 7305-7315
2. Okuno M., Kojima S., Matsushima-Nishiwaki R., et al. Retinoids in cancer chemoprevention. Curr Cancer Drug Targets 4 (2004) 285-298
3. Gaines P., and Berliner N. Retinoids in myelopoiesis. J Biol Regul Homeost Agents 17 (2003) 46-65
4. Idres N., Benoit G., Flexor M.A., Lanotte M., and Chabot G.G. Granulocytic differentiation of human NB4 promyelocytic leukemia cells induced by all-trans retinoic acid metabolites. Cancer Res 61 (2001) 700-705
5. Dragnev K.H., Petty W.J., and Dmitrovsky E. Retinoid targets in cancer therapy and chemoprevention. Cancer Biol Ther 2 4 Suppl 1 (2003) S150-S156
6. Soprano D.R., Qin P., and Soprano K.J. Retinoic acid receptors and cancers. Annu Rev Nutr 24 (2004) 201-221
7. Shoshani T., Faerman A., Mett I., et al. Identification of a novel hypoxia-inducible factor 1-responsive gene, RTP801, involved in apoptosis. Mol Cell Biol 22 (2002) 2283-2293
8. Ellisen L.W., Ramsayer K.D., Johannessen C.M., et al. REDD1, a developmentally regulated transcriptional target of p63 and p53, links p63 to regulation of reactive oxygen species. Mol Cell 10 (2002) 995-1005
9. Wang Z., Malone M.H., Thomenius M.J., Zhong F., Xu F., and Distelhorst C.W. Dexamethasone-induced gene 2 (dig2) is a novel pro-survival stress gene induced rapidly by diverse apoptotic signals. J Biol Chem 278 (2003) 27053-27058
10. Brugarolas J., Lei K., Hurley R.L., et al. Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. Genes Dev 18 (2004) 2893-2904
11. Reiling J.H., and Hafen E. The hypoxia-induced paralogs Scylla and Charybdis inhibit growth by down-regulating S6K activity upstream of TSC in Drosophila. Genes Dev 18 (2004) 2879-2892
12. Corradetti M.N., Inoki K., and Guan K.L. The stress-inducted proteins RTP801 and RTP801L are negative regulators of the mammalian target of rapamycin pathway. J Biol Chem 280 (2005) 9769-9772
13. Schwarzer R., Tondera D., Arnold W., Giese K., Klippel A., and Kaufmann J. REDD1 integrates hypoxia-mediated survival signaling downstream of phosphatidylinositol 3-kinase. Oncogene 24 (2005) 1138-1149
14. Sofer A., Lei K., Johannessen C.M., and Ellisen L.W. Regulation of mTOR and cell growth in response to energy stress by REDD1. Mol Cell Biol 25 (2005) 5834-5845
15. Gery S., Xie D., Yin D., et al. Ovarian carcinomas: CCN genes are aberrantly expressed and CCN1 promotes proliferation of these cells. Clin Cancer Res 11 (2005) 7243-7254
16. Park D.J., Chumakov A.M., Vuong P.T., et al. CCAAT/enhancer binding protein epsilon is a potential retinoid target gene in acute promyelocytic leukemia treatment. J Clin Invest 103 (1999) 1399-1408
17. + cells from normal and myelodysplastic bone marrow. Blood 100 (2002) 3553-3560
18. Gery S., Park D.J., Vuong P.T., Chih D.Y., Lemp N., and Koeffler H.P. Retinoic acid regulates C/EBP homologous protein expression (CHOP), which negatively regulates myeloid target genes. Blood 104 (2004) 3911-3917
19. Lin L., Stringfield T.M., Shi X., and Chen Y. Arsenite induces a cell stress response gene RTP801 through reactive oxygen species and transcription factors Elk-1 and CCAAT/enhancer binding protein. Biochem J 392 (2005) 93-102
20. Hicks C., Johnston S.H., diSibio G., Collazo A., Vogt T.F., and Weinmaster G. Fringe differentially modulates Jagged1 and Delta1 signalling through Notch1 and Notch2. Nat Cell Biol 2 (2000) 515-520
21. Yoshimura K., and Crystal R.G. Transcriptional and posttranscriptional modulation of human neutrophil elastase gene expression. Blood 79 (1992) 2733-2740
22. Hay N., and Sonenberg N. Upstream and downstream of mTOR. Genes Dev 18 (2004) 1926-1945
23. Inoki K., Corradetti M.N., and Guan K.L. Dysregulation of the TSC-mTOR pathway in human disease. Nat Genet 37 (2005) 19-24
24. Weinmann M., Belka C., and Plasswilm L. Tumour hypoxia: impact on biology, prognosis and treatment of solid malignant tumours. Onkologie 27 (2004) 83-90
25. Recher C., Beyne-Rauzy O., Demur C., et al. Antileukemic activity of rapamycin in acute myeloid leukemia. Blood 105 (2005) 2527-2534
26. Witzig T.E., and Kaufmann S.H. Inhibition of the phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway in hematologic malignancies. Curr Treat Options Oncol 7 (2006) 285-294
27. Liu W., Guo M., Xu Y.B., et al. Induction of tumor arrest and differentiation with prolonged survival by intermittent hypoxia in a mouse model of acute myeloid leukemia. Blood 107 (2006) 698-707
28. Lane A.A., and Ley T.J. Neutrophil elastase cleaves PML-RARα and is important for the development of acute promyelocytic leukemia in mice. Cell 115 (2003) 305-318
29. Duan Z., Li F.Q., Wechsler J., et al. A novel notch protein, N2N, targeted by neutrophil elastase and implicated in hereditary neutropenia. Mol Cell Biol 24 (2004) 58-70